2025 Global Market Outlook
The world is transitioning at a pace and scale rarely seen before. Radical innovations in artificial intelligence (AI) and healthcare. Elevated geopolitical tensions, including the raised posibility of tariffs following the U.S. elections. A potential slowdown in global growth. Times like these demand actionable insight and the skill of active management. Here’s what to know to navigate the shifts and opportunities ahead.
Mapping the path from slowdown to recovery
There is strong potential for a slowdown in global growth in early 2025. But central banks are poised to respond with rapid rate cuts, paving the way for a fast recovery. We expect a shift from services to manufacturing—the result of a global push toward renewable energy and the rise of Al. These factors are, in part, fueling infrastructure spending.
Key Takeaway
A recovery in the second half of 2025 will likely hasten the transition to manufacturing-led growth.
U.S. exceptionalism has not run out of steam
The U.S. economy is set for another year of growth, bolstered by investments in AI. Fiscal policies and coordinated monetary easing support this outlook. Job creation will likely slow as companies have front-loaded hiring, but unemployment is expected to remain low. Improving productivity should also provide another boost to growth.
Key Takeaway
Despite a slowing jobs market, supportive monetary policy and improving productivity should keep the U.S. economy out of recession.
Read the Global Market Outlook
Value and small-caps could power international equities
As we emerge from a period dominated by U.S. tech, international equities may offer breadth and room for growth. Diversifying into areas that have valuation support and robust fundamentals, such as value and small-cap stocks, seems prudent to consider. Japan and South Korea could also benefit from structural changes.
Key Takeaway:
We anticipate a broadening opportunity set that favors international markets, particularly value and small-cap stocks.
International small‑cap and large‑cap valuations have converged.
January 30, 2009 through October 31, 2024.
Source: MSCI (see Additional Disclosures). Analysis by T. Rowe Price.
P/E= Price-to-earnings.
Chart shows MSCI All-Country World Indexes, excluding U.S.
Rate cuts provide opportunities for U.S. small-caps and financials
Themes driving the bulk of U.S. equity returns in 2024 may unwind in 2025. Bottom line: We see a broadening opportunity set in equity markets. Small-caps should benefit from further interest rate cuts and any signs of an improving economy. Underappreciated sectors like energy, financials, and industrials could offer opportunities, signaling a stock-pickers' market.
Key Takeaway:
The key trends that dominated U.S. equities in 2024 may fade in 2025, but this will likely expand the opportunity set.
U.S. equity valuations are close to historic highs in many sectors
As of October 31, 2024.
Source: Standard & Poor’s, via FactSet (see Additional Disclosures). Analysis by T. Rowe Price.
Time period range to determine the current relative valuation percentile as of October 31, 2024, is January 1, 1990, through October 31, 2024. Valuations are calculated monthly.
Read the Global Market Outlook
Finding income in high yield bonds, bank loans, and emerging markets
Bond yields have been on a roller-coaster ride as markets pre-empted shifts in central bank policies. Given current market pricing, this implies upside risks to yields. Where to focus: Cash/cash-equivalent yields remain attractive, but longer-duration fixed income is vulnerable. High yield bonds and bank loans are best positioned in our view, while emerging market bonds present favorable growth prospects.
Key Takeaway:
Non‑investment‑grade sectors and emerging market corporate bonds offer attractive yield opportunities even if government bond yields decrease.
Read the Global Market Outlook
Topic in Focus
Weaker growth and lower rates set to open up private markets
Evolving economic and market conditions could expand opportunities for private market investors. Private credit will cater to complex financing needs, while potential IPOs and increased merger and acquisition activity, driven by lower interest rates, may offer liquidity avenues for private equity investors.
Key Takeaway:
A more challenging economic environment and the Fed’s rate‑cutting cycle should open up opportunities for private market investors in 2025.
Radical innovations revealing real prospects in healthcare
A wave of innovation is transforming the health care sector’s prospects. And not just in GLP-1s. Technological developments are leading breakthroughs in AI-led cancer screening and robotic surgery. Therapeutic breakthroughs could have major impacts. A return to lower rates and inventory normalization may also bring a timely boost for the sector.
Key Takeaway:
A new generation of treatments and technologies are paving the way for what could be a golden age in health care.
AI’s “easy money” era is over, but an abundance of opportunities remain
The launch of ChatGPT ignited a surge in Al stocks. While the initial rapid growth phase may be over, Al remains a powerful productivity enhancer for the global economy. What does that mean for investors? Transitioning to Al's next investment phase. Innovative "linchpin" companies—with strong fundamentals—offer the strongest growth prospects.
Key Takeaway:
Investors seeking to navigate the next phase of the AI investment cycle should look for key tech firms that are innovating within growth markets.
Read the Global Market Outlook
Tactical allocation views
Get the T. Rowe Price Multi-Asset Division's expert views on the relative attractiveness of asset classes and subclasses over the next six to 18 months.
Watch the webinar
Hear our investment experts’ dynamic perspective on the state of markets and the economy heading into 2025. Continuing education (CE) credits available for financial professionals.
A destination for all our clients
Visit our experiences tailored to you.
This document reflects the views of the respective associates of T. Rowe Price Associates, Inc., and certain of its investment advisory affiliates. Where noted (articles "U.S. Equities" and "Private Markets"), the views expressed are those of associates of T. Rowe Price Investment Management, Inc., and Oak Hill Advisors, L.P, respectively. The views expressed in this material may differ from the views of other associates and/or T. Rowe Price group companies. T. Rowe Price Associates, Inc. (TRPA), and T. Rowe Price Investment Management, Inc. (TRPIM), have separate research platforms and make investment decisions independently. Oak Hill Advisors, L.P. (OHA), an alternative credit manager, is a T. Rowe Price company.
Views are the opinions of the Global Market Outlook authors as of November 15, 2024.
Active investing may have higher costs than passive investing and may underperform the broad market or passive peers with similar objectives.
T. Rowe Price cautions that economic estimates and forward-looking statements are subject to numerous assumptions, risks, and uncertainties, which change over time. Actual outcomes could differ materially from those anticipated in estimates and forward-looking statements, and future results could differ materially from any historical performance. The information presented herein is shown for illustrative, informational purposes only. Any historical data used as a basis for this analysis are based on information gathered by T. Rowe Price and from third-party sources and have not been independently verified.
Forward-looking statements speak only as of the date they are made, and T. Rowe Price assumes no duty to and does not undertake to update forward-looking statements.
Where securities are mentioned, the specific securities identified and described are for informational purposes only and do not represent recommendations.
Additional Disclosures
For more information on third-party market data please visit troweprice.com/marketdata.
Important Information
This material is being furnished for general informational and/or marketing purposes only. The material does not constitute or undertake to give advice of any nature, including fiduciary investment advice. Prospective investors are recommended to seek independent legal, financial and tax advice before making any investment decision. T. Rowe Price group of companies including T. Rowe Price Associates, Inc. and/or its affiliates receive revenue from T. Rowe Price investment products and services. Past performance is not a reliable indicator of future performance. The value of an investment and any income from it can go down as well as up. Investors may get back less than the amount invested.
The material does not constitute a distribution, an offer, an invitation, a personal or general recommendation or solicitation to sell or buy any securities in any jurisdiction or to conduct any particular investment activity. The material has not been reviewed by any regulatory authority in any jurisdiction.
Information and opinions presented have been obtained or derived from sources believed to be reliable and current; however, we cannot guarantee the sources’ accuracy or completeness. There is no guarantee that any forecasts made will come to pass. The views contained herein are as of the date written and are subject to change without notice; these views may differ from those of other T. Rowe Price group companies and/or associates. Under no circumstances should the material, in whole or in part, be copied or redistributed without consent from T. Rowe Price.
The material is not intended for use by persons in jurisdictions which prohibit or restrict the distribution of the material and in certain countries the material is provided upon specific request. It is not intended for distribution to retail investors in any jurisdiction.
Australia—Issued by T. Rowe Price Australia Limited (ABN: 13 620 668 895 and AFSL: 503741), Level 28, Governor Phillip Tower, 1 Farrer Place, Sydney NSW 2000, Australia. For Wholesale Clients only.
Canada—Issued in Canada by T. Rowe Price (Canada), Inc. T. Rowe Price (Canada), Inc.’s investment management services are only available to Accredited Investors as defined under National Instrument 45-106. T. Rowe Price (Canada), Inc. enters into written delegation agreements with affiliates to provide investment management services.
EEA—Unless indicated otherwise this material is issued and approved by T. Rowe Price (Luxembourg) Management S.à r.l. 35 Boulevard du Prince Henri L-1724 Luxembourg which is authorised and regulated by the Luxembourg Commission de Surveillance du Secteur Financier. For Professional Clients only.
New Zealand—Issued by T. Rowe Price Australia Limited (ABN: 13 620 668 895 and AFSL: 503741), Level 28, Governor Phillip Tower, 1 Farrer Place, Sydney NSW 2000, Australia. No Interests are offered to the public. Accordingly, the Interests may not, directly or indirectly, be offered, sold or delivered in New Zealand, nor may any offering document or advertisement in relation to any offer of the Interests be distributed in New Zealand, other than in circumstances where there is no contravention of the Financial Markets Conduct Act 2013.
Switzerland—Issued in Switzerland by T. Rowe Price (Switzerland) GmbH, Talstrasse 65, 6th Floor, 8001 Zurich, Switzerland. For Qualified Investors only.
UK—This material is issued and approved by T. Rowe Price International Ltd, Warwick Court, 5 Paternoster Square, London EC4M 7DX which is authorised and regulated by the UK Financial Conduct Authority. For Professional Clients only.
ID0007461
202411-4019625